A randomized study of the immunogenicity and safety of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in comparison with SA14-14-2 Vaccine in children in the Republic of Korea

A new live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) has been developed based on innovative technology to give protection against JE with an improved immunogenicity and safety profile. In this phase 3, observer-blind study, 274 children aged 12−24 months were randomized 1:1 to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Dong Soo, Houillon, Guy, Jang, Gwang Cheon, Cha, Sung-Ho, Choi, Soo-Han, Lee, Jin, Kim, Hwang Min, Kim, Ji Hong, Kang, Jin Han, Kim, Jong-Hyun, Kim, Ki Hwan, Kim, Hee Soo, Bang, Joon, Naimi, Zulaikha, Bosch-Castells, Valérie, Boaz, Mark, Bouckenooghe, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977450/
https://www.ncbi.nlm.nih.gov/pubmed/25483480
http://dx.doi.org/10.4161/hv.29743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977450/
https://www.ncbi.nlm.nih.gov/pubmed/25483480
http://dx.doi.org/10.4161/hv.29743

Ejemplares similares